发明名称 Novel compounds for treating inflammatory diseases
摘要 Heteroaryl derivatives (1) and their racemates, enantiomers, diastereomers, acid addition salts, solvates, hydrates and deuterated forms are new. Heteroaryl derivatives of formula (1) and their racemates, enantiomers, diastereomers, acid addition salts, solvates, hydrates and deuterated forms are new. A : CO, C=NH, 1-6C alkylene or 3-8C cycloalkylene; B 1> : phenyl or an aromatic or non-aromatic ring optionally containing two or three heteroatoms of O, S or N and optionally substituted with OH, O-1-6C alkyl, O-1-6C-haloalkyl, halo, 1-6C alkyl or 1-6C haloalkyl; B 2> : phenyl or hetero aryl containing 2 or 3 heteroatoms of O, S or N; X : e.g. O or S; n : 0-3; either R 1> : e.g. H, 1-6C alkyl, 1-6C haloalkyl; and R 2> : H, 1-6C alkyl or 1-6C haloalkyl; or NR 1>R 2> : non-aromatic heterocycle containing 2 or 3 heteroatoms of O or N; or R 2>+N+A+B 1> : bicyclic group of formula (g); A : CO, C=NH or 1-3C alkyl; m : 1-3; B 1> : sulfonyl compound of formula (h); Z 1> : H, OH, halo, 1-6C alkyl, 1-6C alkanol, O(1-6C alkyl), 6-10C aryl, O-6-10C aryl, NH 2, NH(1-6C alkyl), N(1-6C) alkyl or 3-7C cycloalkyl; and R 4> : e.g. 1-6C alkyl, 3-8C cycloalkyl, 1-6C haloalkyl, CN or halo. Full definitions are given in the DEFINITIONS (Full Definitions) Field. Independent claims are included for: (1) a medicament combination comprising (1) and further active substance, such as beta-mimetic, anticholinergic, corticosteroid, further phosphodiesterase-4-inhibitors, leukotriene D4 antagonists, epidermal growth factor receptor inhibitor, dopamine agonists, H1-antihistaminic, platelet-activating factor antagonist and/or phosphatidylinositol-3 kinase inhibitor; and (2) intermediate compounds of formula (i-iii) or (I-V). PG : H or a suitable protection group; and G : NO 2 or NH 2. [Image] [Image] [Image] [Image] [Image] ACTIVITY : Gastrointestinal-Gen.; Antidepressant; Neuroleptic; Antimanic; Neuroprotective; Nootropic; Antiparkinsonian; Analgesic; Cerebroprotective; CNS-Gen.; Respiratory-Gen.; Antiasthmatic; Antiinflammatory; Antiulcer. MECHANISM OF ACTION : Phosphodiesterase-4 enzyme inhibitor.
申请公布号 ZA200707592(B) 申请公布日期 2008.10.29
申请号 ZA20070007592 申请日期 2007.09.04
申请人 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 发明人 WALTER, RAINER;KLEY, JOERG;GOEGGEL, ROLF;MACK, JUERGEN;ANDERSKEWITZ, RALF;DOLLINGER, HORST;JUNG, BIRGIT;NICKOLAUS, PETER
分类号 A61K;A61P;C07D 主分类号 A61K
代理机构 代理人
主权项
地址
您可能感兴趣的专利